Omkar Pharmachem Share Price
9.26-0.48 (-4.93%)
-63.77% past 1 Year
Omkar Pharmachem Ltd is engaged in the manufacturing of pharmaceutical chemicals.The product range of the company includes sodium bi-sulphite, sodium meta bi-sulphite, sodium sulphite, and sulphur.
Corporate filings & documents
Announcements
Dear Sir Please find Newspaper Publication under Reg 47 of SEBI (LODR) Regulations 2015 regarding the 31st Annual General Meeting of the Company.
21 hours agoDear Sir Please find Newspaper Publication under Reg 47 of SEBI (LODR) Regulations 2015 regarding the 31st Annual General Meeting of the Company.
21 hours agoDear Sir Please find intimation under regulation 42 of SEBI Listing Obligations and Disclosure Requirements) Regulations 2015
2 days agoDear Sir Please find intimation under regulation 42 of SEBI Listing Obligations and Disclosure Requirements) Regulations 2015
2 days ago31st Annual Report of the company along with Notice of AGM for the Financial year 2025-26
2 days ago31st Annual Report of the company along with Notice of AGM for the Financial year 2025-26
2 days agoPursuant to Regulation 30 of SEBI( Listing Obligations and Disclosures requirements) Regulations 2015 Please find attached herewith the Notice convening 31st Annual General Meeting of the Company
2 days agoPursuant to Regulation 30 of SEBI( Listing Obligations and Disclosures requirements) Regulations 2015 Please find attached herewith the Notice convening 31st Annual General Meeting of the Company
2 days agoOutcome of the Board Meeting held on 31st August 2026
3 days agoOutcome of the Board Meeting held on 31st August 2026
3 days agoDear Sir Please find publication of results for the quarter ended 30.06.2026.
2 weeks agoDear Sir Please find publication of results for the quarter ended 30.06.2026.
2 weeks agoDear Sir Pursuant to provisions of Reg. 33 of SEBI (LODR)Regulations 2015 please find Unaudited Financial Results for the Quarter ended on 30.06.2026
3 weeks agoDear Sir Pursuant to provisions of Reg. 33 of SEBI (LODR)Regulations 2015 please find Unaudited Financial Results for the Quarter ended on 30.06.2026
3 weeks agoPursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please note that the Board in their meeting held on 13 August 2026 has considered and approved the following business:1. Unaudited Financial Results of the Company alongwith Limited Review Report for the quarter ended on 30" June 2026.
3 weeks agoPursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please note that the Board in their meeting held on 13 August 2026 has considered and approved the following business:1. Unaudited Financial Results of the Company alongwith Limited Review Report for the quarter ended on 30" June 2026.
3 weeks agoOmkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Unaudited Financial result for the quarter ended on June 30 2026 along with Limited Review Report thereof.
4 weeks agoOmkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Unaudited Financial result for the quarter ended on June 30 2026 along with Limited Review Report thereof.
4 weeks agoNewspaper Advertisment regarding special Window
1 month agoNewspaper Advertisment regarding special Window
1 month agoDear Sir/Maam Please find Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018 for the Quarter ended 30.06.2026
1 month agoDear Sir/Maam Please find Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018 for the Quarter ended 30.06.2026
1 month agoDear Sir/Maam Please find Certificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended 30.06.2026.
1 month agoDear Sir/Maam Please find Certificate under Reg 74(5) of SEBI (DP) Regulations 2018 for the Quarter ended 30.06.2026.
1 month agoDear Sir Please find Intimation for closure of trading window of Omkar Pharmachem Limited.
2 months agoDear Sir Please find Intimation for closure of trading window of Omkar Pharmachem Limited.
2 months agoDear Sir Please find attached copy of News Paper Publication in which Audited Financial Results for the Quarter and Year ended 31st March 2026 are published one in English and one in Vernacular language.
3 months agoDear Sir Please find attached copy of News Paper Publication in which Audited Financial Results for the Quarter and Year ended 31st March 2026 are published one in English and one in Vernacular language.
3 months agoDear Sir/Maam Please find Financial Results for the quarter and year ended 31.03.2026
3 months agoDear Sir/Maam Please find Financial Results for the quarter and year ended 31.03.2026
3 months agoDear Sir Please find Outcome of the Board Meeting held on 30 May 2026 of Omkar Pharmachem Limited
3 months agoDear Sir Please find Outcome of the Board Meeting held on 30 May 2026 of Omkar Pharmachem Limited
3 months agoDear Sir/Maam Please find Annual Secretarial Compliance report for the year ended 31.03.2026 of Omkar Pharmachem Limited.
3 months agoOmkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Omkar Pharmachem Ltd. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Audited Financial results for quarter and year ended on 31st March 2026.
3 months agoOmkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Omkar Pharmachem Ltd. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Audited Financial results for quarter and year ended on 31st March 2026.
3 months agoDear Sir/Maam Please find Intimation under Reg 30 of SEBI (LODR) Regulations 2015 for change in name of Managing Director of the company.
3 months agoDear Sir Please find Newspaper Publication regarding Special Window for Transfer & Demat of Physical Shares.
3 months agoDear Sir/Maam Please find Certificate under Ref. 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended 31.03.2026.
4 months agoDear Sir/Maam Please find Certificate under Ref. 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended 31.03.2026.
4 months agoDear Sir Pursuant to SEBI (LODR) 2015 as amended and in compliance with the terms of Code of Conduct of the company please note that the Trading Window for dealing in the securitites of the company will remain closed fir the designated persons and their immediate relatives from Wednesday 01.04.2026 till the completion of 48 hours after the daye of declaration of Audited Financial results for the quarter and Year ended on 31.03.2026.
5 months agoDear Sir Pursuant to SEBI (LODR) 2015 as amended and in compliance with the terms of Code of Conduct of the company please note that the Trading Window for dealing in the securitites of the company will remain closed fir the designated persons and their immediate relatives from Wednesday 01.04.2026 till the completion of 48 hours after the daye of declaration of Audited Financial results for the quarter and Year ended on 31.03.2026.
5 months agoDear Sir/Maam Please find Newspaper Publication regarding special window for transfer and dematerialization of physical shares.
5 months agoDear Sir/Maam Please find additional details required for the Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations 2015.
6 months agoDear Sir/Maam Please find additional details required for the Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations 2015.
6 months agoDear Sir Please find Newspaper Advertisement for the Unaudited Financial Results for the quarter and nine months ended on 31.12.2025.
6 months agoDear Sir Please find Newspaper Advertisement for the Unaudited Financial Results for the quarter and nine months ended on 31.12.2025.
6 months agoDear Sir/Maam Please find unaudited financial results for the quarter and nine months ended on 31.12.2025
6 months agoDear Sir/Maam Please find unaudited financial results for the quarter and nine months ended on 31.12.2025
6 months agoDear Sir Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please note that the Board in their meeting held on 14th February 2026 has considered and approved the following business: 1. The Board approved the Unaudited Financial Results of the Company along with the Limited Review Report for the quarter and Nine Months ended on 31st December 2025. The Board took note of the completion of the tenure of Mr. Janak Raj Sharma (DIN: 07420418) as an Independent Director of the Company. Mr. Janak Raj Sharma has completed two consecutive terms of five (5) years each and accordingly ceased to be an Independent Director of the Company upon the close of business hours on 12th February 2026.
6 months agoDear Sir Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 please note that the Board in their meeting held on 14th February 2026 has considered and approved the following business: 1. The Board approved the Unaudited Financial Results of the Company along with the Limited Review Report for the quarter and Nine Months ended on 31st December 2025. The Board took note of the completion of the tenure of Mr. Janak Raj Sharma (DIN: 07420418) as an Independent Director of the Company. Mr. Janak Raj Sharma has completed two consecutive terms of five (5) years each and accordingly ceased to be an Independent Director of the Company upon the close of business hours on 12th February 2026.
6 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
310, Wall Street- I Near Gujarat College Cross Road Ellisbridge Ahmedabad Gujarat PIN: 380006 Tel No: 079-26580892 / 9711811163 Fax No: 079-30071411 Email: [email protected] Internet: www.omkarpharmachem.co.in
Registrars
205-208 , Anarkali Complex,Jhandewala Extension,New Delhi 205-208 , Anarkali Complex Jhandewala Extension NULL PIN: Tel No: 011-23610220-24 Fax No: 011-23552001 Email: NULL
Management
Bhawani Shankar Goyal, Managing Director
Parminder Sharma, Non Executive Director
Surjeet Kaur, Non Executive Independent Director
Anupam Kumar Mishra, Non Executive Independent Director
Pankaj Singh, Company Secretary & Compliance Officer
Details
BSE 532167
NSE NULL
ISIN INE501C01015